MedPlus Health Services Limited has announced a temporary five-day suspension of a drug license for one of its stores located in Samta Nagar, Nashik. The suspension, which was officially communicated to the company on May 6, 2026, is due to alleged contraventions of established pharmaceutical regulations. The company anticipates a minimal financial impact, estimating a potential revenue loss of approximately Rs 0.75 lacs resulting from this short-term operational closure.
Suspension Details
The subsidiary of MedPlus Health Services Limited, Optival Health Solutions Private Limited, has received a directive from the local pharmaceutical authority regarding one of its retail outlets. The order mandates the suspension of the drug license for a duration of five days for the store situated in Samta Nagar, Nashik, following allegations of non-compliance with the Drugs and Cosmetics Act.
Financial and Operational Impact
The company has confirmed that the suspension is localized to this specific retail location. To maintain transparency with stakeholders, management has quantified the potential financial impact of this disruption. The company estimates a total revenue loss of Rs 0.75 lacs during the five-day period. Operations at all other locations remain unaffected, and the company is taking necessary steps to address the compliance requirements for the affected store.
Source: BSE
